Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/09/021214
CTRI/2019/09/021214
Not yet recruiting
未知

Assessment and comparison of bone marker levels and bone density in PCOS subjects with or without Chronic Periodontitis before and after non surgical periodontal therapy - PCOS-CP

SERB DST0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: R888- Abnormal findings in other body fluids and substancesHealth Condition 2: E282- Polycystic ovarian syndrome

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: R888- Abnormal findings in other body fluids and substancesHealth Condition 2: E282- Polycystic ovarian syndrome
Sponsor
SERB DST
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
SERB DST

Eligibility Criteria

Inclusion Criteria

  • •Women between 18 and 30 years of age.
  • •2\. PCOS diagnosis will be based on the criteria by Rotterdam2 with the presence of at least two of the following: polycystic ovaries, oligomenorrhea and/or anovulation, hyperandrogenism (clinical and/or biochemical)
  • •3\. Diagnosis of generalized moderate\-to\-severe chronic periodontitis will be based on presence of at least 20 teeth in the oral cavity, with at least 30% of the areas undergoing clinical attachment loss of at least 3 mm and a probing depth of \>\=5 mm and radiographic evidence of bone loss3\.
  • •4\. The systemically healthy group will be based on; history of regular menstrual cycles, no clinical or biochemical sign of hyperandrogenism, matching with the PCOS group in body mass index (BMI) and exclusion of PCOS by ultrasound examination.
  • •5\. Willingness to sign consent for study including participation with collection of blood specimens
  • •6\. Willingness to discontinue OCP for duration of study period up to 18 weeks

Exclusion Criteria

  • •2\. History of smoking or any drug usage, including oral contraceptives, systemic antibiotics (during the previous 6 months) or continuous use of NSAIDs
  • •3\. History of any dental treatment in the previous six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Assessment of bone related bio-markers in patients with rheumatoid arthritis treated with Certolizumab pegolrheumatoid arthritis
JPRN-UMIN000029594Graduate School of Medicine, Osaka University Department of Respiratory Medicine and Clinical Immunology40
Completed
Phase 4
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate CancerProstate Cancer
NCT00391690Novartis99
Recruiting
Phase 2
Evaluation of marginal bone level around short maxillary implants
IRCT2017021025662N2Vice chancellor for research, Tehran University of Medical Sciences16
Not yet recruiting
Phase 2
Effect of 1% Metformin gel on bone density.
CTRI/2024/05/067922Dr Tushar Mohata
Not yet recruiting
Not Applicable
Comparing bone strength and implant stability in people with high cholesterol levelsHealth Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
CTRI/2024/07/070551Datta Meghe Institute of Higher Education and Research